Friday, August 28, 2020 10:57:52 AM
"All patients had known chronic diseases. The most common comorbidities prior to admission were hypertension (4/6) and chronic kidney disease (4/6). Two patients have known diabetes mellitus, with Patient 6 being insulin-dependent. Three of the patients had undergone solid organ transplants and were treated with immunosuppressive agents. Patient 2 received a double lung transplant and was treated for antibody-mediated rejection (AMR) one month before presentation. Patient 1 was also diagnosed with a non-ST-elevation myocardial infarction (NSTEMI) during her admission (Table 1). All patients had lab values suggestive of diffuse inflammatory processes including elevated ferritin (5/6), IL-6 (4/6), lactate dehydrogenase (3/6), and C-reactive protein (3/6)."
I think they are getting their ducks in a row to prepare for all the inevitable scrutiny. The cases and overall results are not new, but these details are new... and very impressive.
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM
Reliant Coffee Debuts at #271 on the Inc. 5000 List of Fastest Growing Companies - Coffee Service Industry Disruptor Brews Up Exponential Growth Sep 5, 2024 11:51 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • MFL • Sep 4, 2024 9:02 AM
Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • INTV • Sep 4, 2024 8:45 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM